Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients

被引:12
作者
Bush, CE [1 ]
Donovan, RM [1 ]
Manzor, O [1 ]
Baxa, D [1 ]
Moore, E [1 ]
Cohen, F [1 ]
Saravolatz, LD [1 ]
机构
[1] CHILDRENS HOSP MICHIGAN,DEPT PEDIAT,DETROIT,MI 48201
关键词
D O I
10.1089/aid.1996.12.11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Better surrogate markers need to be developed to evaluate therapy in HIV-infected children, This study evaluated plasma RNA, immune complex-dissociated p24 antigenemia, and unintegrated DNA (uDNA) in HIV-infected pediatric patients, Ten children were followed from initiation of nucleoside antiretroviral therapy at intervals up to 24 months, Prior to initiation of therapy, HIV RNA was detected in 10 of 10 patients (median, 76,000 Eq/ml), p24 antigen was detected in 8 of 10 patients (median, 193 pg/ml), and uDNA was detected in 6 of 7 patients (median, 10% uDNA), After 12 months the RNA decreased in all patients and became undetectable in six, In contrast, p24 antigenemia decreased in 6 of 10 patients, remained undetectable in 1, and increased in 3, HIV uDNA decreased in six of six patients and became undetectable in three, There was no overall change in CD4 cell count, Plasma RNA and uDNA levels are both sensitive markers of nucleoside therapy in children; however, they do not covary strongly.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 31 条
[11]  
DONOVAN RM, 1994, J ACQ IMMUN DEF SYND, V7, P1237
[12]   RAPID DECREASE IN UNINTEGRATED HUMAN-IMMUNODEFICIENCY-VIRUS DNA AFTER THE INITIATION OF NUCLEOSIDE THERAPY [J].
DONOVAN, RM ;
BUSH, CE ;
SMERECK, SM ;
BAXA, DM ;
MARKOWITZ, NP ;
SARAVOLATZ, LD .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :202-205
[13]   HIV-1 QUANTIFICATION IN INFECTED CHILDREN BORN TO SEROPOSITIVE MOTHERS [J].
FERRONI, A ;
MAYMAT, D ;
BLANCHE, S ;
ORTIGAO, MB ;
BURGARD, M ;
IVANOFF, S ;
ROUZIOUX, C .
AIDS, 1993, 7 (09) :1271-1272
[14]   USE OF VIROLOGICAL ASSAYS FOR DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN CLINICAL-TRIALS - RECOMMENDATIONS OF THE AIDS CLINICAL-TRIALS GROUP VIROLOGY COMMITTEE [J].
HAMMER, S ;
CRUMPACKER, C ;
DAQUILA, R ;
JACKSON, B ;
LATHEY, J ;
LIVNAT, D ;
REICHELDERFER, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) :2557-2564
[16]  
LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63
[17]   MULTICENTER EVALUATION OF QUANTIFICATION METHODS FOR PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA [J].
LIN, HJ ;
MYERS, LE ;
YENLIEBERMAN, B ;
HOLLINGER, FB ;
HENRARD, D ;
HOOPER, CJ ;
KOKKA, R ;
KWOK, S ;
RASHEED, S ;
VAHEY, M ;
WINTERS, MA ;
MCQUAY, LJ ;
NARA, PL ;
REICHELDERFER, P ;
COOMBS, RW ;
JACKSON, JB .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :553-562
[18]   SAFETY AND TOLERANCE OF INTERMITTENT INTRAVENOUS AND ORAL ZIDOVUDINE THERAPY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PEDIATRIC-PATIENTS [J].
MCKINNEY, RE ;
PIZZO, PA ;
SCOTT, GB ;
PARKS, WP ;
MAHA, MA ;
LEHRMAN, SN ;
RIGGS, M ;
EDDY, J ;
LANE, BA ;
EPPES, SC ;
WILFERT, CM .
JOURNAL OF PEDIATRICS, 1990, 116 (04) :640-647
[19]   A MULTICENTER TRIAL OF ORAL ZIDOVUDINE IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].
MCKINNEY, RE ;
MAHA, MA ;
CONNOR, EM ;
FEINBERG, J ;
SCOTT, GB ;
WULFSOHN, M ;
MCINTOSH, K ;
BORKOWSKY, W ;
MODLIN, JF ;
WEINTRUB, P ;
ODONNELL, K ;
GELBER, RD ;
ROGERS, GK ;
LEHRMAN, SN ;
WILFERT, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (15) :1018-1025
[20]   HIGH-LEVELS OF HIV-1 IN PLASMA DURING ALL STAGES OF INFECTION DETERMINED BY COMPETITIVE PCR [J].
PIATAK, M ;
SAAG, MS ;
YANG, LC ;
CLARK, SJ ;
KAPPES, JC ;
LUK, KC ;
HAHN, BH ;
SHAW, GM ;
LIFSON, JD .
SCIENCE, 1993, 259 (5102) :1749-1754